What is The Concinnity?
The Concinnity operates at the intersection of health-tech and regulatory compliance, providing a sophisticated software suite tailored for Data Safety Monitoring Boards (DSMB) and Data Monitoring Committees. Its flagship Cloud Concinnity platform serves as a centralized hub for data collection, rigorous analysis, and real-time reporting. By digitizing and streamlining the oversight process, the company addresses the persistent industry challenges of patient safety, operational cost-effectiveness, and the urgent need to reduce time-to-market for new therapeutic treatments. The platform is engineered to enhance collaboration among stakeholders, ensuring that clinical trial data remains both transparent and compliant with evolving global standards.
How much funding has The Concinnity raised?
The Concinnity has raised a total of $329K across 2 funding rounds:
Debt
$150K
Debt
$179K
Debt (2020): $150K with participation from PPP
Debt (2021): $179K led by PPP
Key Investors in The Concinnity
PPP
Public-Private Partnership
What's next for The Concinnity?
With this late-stage capital, The Concinnity is well-positioned to scale its operations and deepen its market penetration. The strategic focus will likely shift toward expanding the capabilities of the Cloud Concinnity platform to accommodate more complex, multi-site global trials. By leveraging this investment, the company aims to solidify its role as an essential partner for pharmaceutical and biotech firms, potentially accelerating the adoption of its oversight tools in emerging markets. As the clinical trial landscape becomes increasingly data-intensive, The Concinnity's commitment to enhancing decision-making efficiency will be a key driver of its long-term growth trajectory and competitive advantage in the life sciences software market.
See full The Concinnity company page
